- Home
- TANH vs GRI Comparison
TANH vs GRI Comparison
Compare TANH & GRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TANH
- GRI
- Stock Information
- Founded
- TANH 2001
- GRI 2018
- Country
- TANH China
- GRI United States
- Employees
- TANH N/A
- GRI N/A
- Industry
- TANH
- GRI Biotechnology: Pharmaceutical Preparations
- Sector
- TANH
- GRI Health Care
- Exchange
- TANH Nasdaq
- GRI Nasdaq
- Market Cap
- TANH 3.5M
- GRI 3.2M
- IPO Year
- TANH 2015
- GRI N/A
- Fundamental
- Price
- TANH $2.00
- GRI $1.26
- Analyst Decision
- TANH
- GRI Strong Buy
- Analyst Count
- TANH 0
- GRI 2
- Target Price
- TANH N/A
- GRI $22.00
- AVG Volume (30 Days)
- TANH 33.3K
- GRI 112.3K
- Earning Date
- TANH 07-07-2025
- GRI 08-13-2025
- Dividend Yield
- TANH N/A
- GRI N/A
- EPS Growth
- TANH N/A
- GRI N/A
- EPS
- TANH N/A
- GRI N/A
- Revenue
- TANH $42,940,136.00
- GRI N/A
- Revenue This Year
- TANH N/A
- GRI N/A
- Revenue Next Year
- TANH N/A
- GRI N/A
- P/E Ratio
- TANH N/A
- GRI N/A
- Revenue Growth
- TANH N/A
- GRI N/A
- 52 Week Low
- TANH $1.45
- GRI $1.10
- 52 Week High
- TANH $38.40
- GRI $43.69
- Technical
- Relative Strength Index (RSI)
- TANH 45.28
- GRI 40.16
- Support Level
- TANH $1.95
- GRI $1.28
- Resistance Level
- TANH $2.14
- GRI $1.45
- Average True Range (ATR)
- TANH 0.14
- GRI 0.11
- MACD
- TANH -0.01
- GRI 0.03
- Stochastic Oscillator
- TANH 21.21
- GRI 29.30
About TANH Tantech Holdings Ltd.
Tantech Holdings Ltd manufactures bamboo charcoal-based products. The company through its subsidiaries is engaged in the production and distribution of household products along with a trading business which involves the export of charcoal products. It also manufactures electric double-layer capacitors carbon materials and low-emission barbecue charcoal. Its product portfolio includes air purifiers and humidifiers, underfloor humidity control, pillows and mattresses, wardrobe deodorizers, mousepads, and wrist mats, refrigerator deodorant, and charcoal toilet cleaner disks. The company has two reportable segments; the Consumer Product segment, and the Electric Vehicle (EV) segment.
About GRI GRI Bio Inc.
GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI Bio's program, GRI-0621, is a small molecule RAR-beta and gamma dual agonist that inhibits the activity of human NKT I cells, returning the immune system to homeostasis. It is also an oral formulation of tazarotene, a synthetic RAR-beta and gamma selective agonist for the topical treatment of psoriasis and acne. The company's other product candidate GRI-0803 is a novel oral agonist of type 2 Natural Killer T (type 2 NKT) cells which can be a potential treatment for autoimmune disorders.